Background: The evaluation of ammonia detoxification by pre-and probiotics by means of colonic lactose-[ 15 N 2 ]ureide ( 15 N-LU) degradation is of great interest both scientifically and in terms of nutrition physiology. Objective: Pre-and probiotics were supplemented in healthy adults to evaluate the effect of the ammonia metabolism in the human colon by means of 15 N-LU. Methods: A total of 14 participants aged 20-28 years daily received a regular diet either without (no treatment) or with supplementation of 30 g fibre of potatoes (FPs), 30 g wrinkle pea starch (WPS, resistant starch content: 12 and 70%, respectively) and 375 g Lactobacillus acidophilus (LC1) yoghurt, over a 10-day period in a randomised order. After 1 week, 5.7 mg/kg body weight 15 N-LU was administered together with breakfast. A venous blood sample was taken after 6 h. Urine and faeces were collected over a period of 48 and 72 h, respectively. The 15 N abundances were measured by isotope ratio mass spectrometry. Results: The mean renal 15 N-excretion differed significantly between the supplementation of FP and no treatment (32.5 versus 46.3%, P ¼ 0.034), FP and LC1 (32.5 versus 51.6%, P ¼ 0.001), and WPS and LC1 (38.5 versus 51.6%, P ¼ 0.048). The mean faecal 15 N-excretion amounted to 42.7% (no treatment), 59.7% (FP), 41.8% (WPS) and 44.0% (LC1). In comparison with no treatment, the urinary 15 NH 3 -enrichment was significantly decreased at 16 h after FP supplementation. Conclusion: The prebiotic intake of FP and WPS lowered the colonic generation and the renal excretion of toxic 15 NH 3 , respectively, when using 15 N-LU as a xenobiotic marker.
Introduction
In recent years, 15 N-labelled lactose ureide ( 15 N-LU) has been successfully used for studying colonic nitrogen and ammonia metabolism, respectively, to assess the effects of pre-and probiotics on the human intestinal flora (Jackson et al., 2004; , 2008 Geboes et al., 2006; Cloetens et al., 2008a) . The molecular bond between the sugar moiety and urea of shown to resist enzymatic degradation in the small bowel, but to be split by Clostridium innocuum in the caecum (Heine et al., 1995; Mohr et al., 1999; Wutzke and Glasenapp, 2004 ; Wutzke and Schütt, 2007) . 15 N-LU has the advantage of supplying both the nitrogen and the energy needed for microbial protein synthesis simultaneously and has therefore been used as a carrier for transporting 15 NH 3 (common abbreviation for the ammonia/ammonium equilibrium 15 NH 3 þ H 3 O þ 2
15
NH 4 þ þ H 2 O shifted to the ammonium side under physiological conditions) into the colon. Probiotics are defined as viable microorganisms that have beneficial effects in the prevention and treatment of specific pathologic conditions in the gut (Fuller, 1989) . Human in vivo studies have proven that Lactobacillus johnsonii, formerly known as Lactobacillus acidophilus ( La1 and LC1, respectively) , supports the physiological function of the gastrointestinal tract and stimulates the immune defence system (Pfeiffer and Rosat, 1999) . Prebiotics are defined as nondigestible food ingredients, mainly oligosaccharides, nondigestible polysaccharides, resistant starches, and others that support the growth of certain bacteria such as lactobacilli and bifidobacteria that have various beneficial effects on the gut, and, consequently, for the health of the host (Gibson and Roberfroid, 1995) . Prebiotics have the ability of increasing the saccharolytic activity, but contrastingly to decrease the proteolytic activity of the microbiota of the gut (Swanson et al., 2002) . The colonic microbiota is responsible for degrading proteins partly to potentially toxic metabolites such as ammonia, amines and others which are implicated in the pathogenesis of different diseases (Smith and Macfarlane, 1996) . It is assumed that ammonia is assimilated systematically by the bacteria, resulting in reduced urinary excretion and corresponding increased faecal excretion. The scientific literature previously provided evidence that the consumption of probiotics and prebiotics containing resistant starch and other non-digestible carbohydrates may influence the bacterial production of toxic metabolic end products, particularly ammonia, in the human colon (Cummings and Macfarlane, 2002; De Preter et al., 2004; Geboes et al., 2005 
Methods
Tracer substance and supplements 15 N-LU was synthesised according to our method as described in detail previously (Wutzke et al., 1997) . Lactose was obtained from Merck Darmstadt, Germany, whereas [ 15 N 2 ]urea (99 atom%) was obtained from Campro Scientific Berlin, Germany. FP and WPS, with a RS1 content of 12% and a RS2 content of 70%, respectively, were provided from the manufacturer Emsland Group GmbH Emlichheim, Germany, whereas the LC1 yoghurt pure (colony forming units: 2.6 Â 10 9 /100 g, calorific value: 75 kcal/100 g) was used from Nestlé AG, Frankfurt/Main, Germany. Table 1 shows the detailed composition of both starch products as well as the LC1 yoghurt. Both FP and WPS are commercially available and are commonly used as supplements in bakery as well as in meat products.
Participants
In all, 14 healthy adults (9 female, 5 male, age: 20-28 years, body weight: 51.5-107.3 kg) volunteered for this study. They were in good health throughout the study. None of the participants were receiving any medication or had a history of gastrointestinal diseases. Furthermore, none of the participants regurgitated after having received the preand probiotics and the 
Study protocols
All volunteers received an individually standardised regular diet (carbohydrate, fat and protein content 55%, 30% and 15%, respectively) over a time span of 54 days. According to the precursor studies of the Leuven group, no standard diets were imposed (De De Preter et al., 2004 , 2008 Cloetens et al., 2008b) . Nevertheless, the volunteers were urged to keep their usual dietary habits, with taken care that their diet remained as constant as possible within the four test phases. On the days of 15 N-LU administration, the breakfast was identical in all the 14 participants. All volunteers received a continental breakfast made up of 1 wheat flour roll, 50 g jam, 50 g cheese and 1 cup of tea at 07:45 hours. No other food or drink was allowed until 6 h after breakfast. Blood, urine and faeces samples were taken 30 min before the ingestion of pulse strewn on a small area of the jam to ingest the label with one bite. A sample of venous blood was taken 6 h after 15 N-tracer administration at 14:00 hours. On the first and on the second day, the urine was collected quantitatively in 2-and 4-, and in 6-h intervals, respectively, whereas faeces were collected quantitatively over 72 h. After a 4-day washout phase, four participants each received either 10 g FP, 10 g WPS (dissolved in 100 ml tea), or 125 g LC1 (the equivalent of one yoghurt cup) together with breakfast, lunch and dinner at 8:00, 13:00, and 19:00 hours, respectively, in randomised order over a 10-day period. The 15 N-LU administration was repeated on the twenty-third day followed by the wash-out phase. On the thirth day, the randomised cross-over procedure was repeated with the next pre-or probiotic supplement followed by the 15 N-tracer administration on the thirty-seventh day. After the wash-out period, the test was repeated with the remaining substance on the fourty-fourth day followed by the final 15 N-LU administration ( Figure 1 ). The procedure of 15 N-LU administration, blood, urine and faeces collection was identical in all four tests. The 10-day supplementation period includes the complete collection of urine and faeces, whereas 15 N-LU was administered on the seventh day of the respective pre-or probiotic supplementation (Figure 1 ).
Sample preparation
The sample preparation before the isotope ratio mass spectrometry (IRMS) analysis has been recently explained in detail ( Wutzke and Sattinger, 2006) . After centrifugation of the citrated blood sample, the plasma was treated with sulphuric Na 2 WO 4 . The soluble supernatant was removed by centrifugation and was stored at À20 1C until analysis (Faust et al., 1981) . After defrosting, 0.5 ml supernatant was transferred to tin boats and was dried at 60 1C for 2 h. Urine volumes and faecal masses scraped from polyvinyl film were homogenised, recorded and stored at À20 1C until analysis (Wutzke and Oetjens, 2005) . After defrosting, 25 ml of urine was transferred to tin boats, whereas 5 mg wet faeces were weighed on tin discs. Urinary ammonia was separated in vessels by microdiffusion, following alkalisation of the urine with NaOH and trapped in boric acid (Faust et al., 1981) .
Analytical techniques
Supernatant, urine and faeces samples were combusted in the elemental analyser SL (SerCon, Crewe, UK) using copper oxide at 900 1C and subsequently reduced to nitrogen gas using copper at 600 1C. Thereafter, the 15 Pre-and probiotics on colonic ammonia metabolism KD Wutzke et al
Statistical method
The Kolmogorov-Smirnow test was used for testing the distribution normality. Then, the factorial one-and two-way analysis of variance using a post hoc Bonferroni correction for multiple comparisons on programme SPSS 15.0 for Windows were used for statistical analysis of the total N-, the faecal 15 N-and the urinary 15 N-excretion, respectively, (Tables 2-4) whereas the Kruskal-Wallis and the Mann-Whitney U-test were used for the urinary 15 NH 3 -enrichment (significance Pp0.01). All results are quoted as means ± s.d.
Results
The maximum 15 N-enrichments in urinary ammonia
were reached 12 h after 15 N-LU administration in all four tests (no treatment, FP, WPS and LC1 supplementation) averaging 0.027 ± 0.019, 0.018 ± 0.024, 0.023 ± 0.019 and 0.029 ± 0.018, atom%exc, respectively (Figure 2) . After 48 h, the mean renal percentage cumulative excretion amounted to 46.3 ± 11.1, 32.5 ± 8.0, 38.5 ± 12.9 and 51.6 ± 16.9% (Table 2) , respectively, whereas after 72 h, the mean total faecal excretion amounted to 42.7±20.6, 59.7±24.4, 41.8 ± 26.9 and 44.0 ± 21.7%, respectively (Table 3 ). The urine fractionation in intervals of 0-6 h, 6-24 h and 24-48 h revealed that the major part of 15 N was excreted between 6-24 h ( Table 2 ). The resulting total 15 N-exretion (urine þ faeces) shows that 89.0, 92.2, 80.2 and 95.6%, respectively, of the ingested dose were excreted. The measured 15 N-enrichments in the supernatant amounted to 0.036± 0.015, 0.040 ± 0.024, 0.041 ± 0.017, and 0.036 ± 0.020 atom%exc, respectively, whereas the respective numbers of the plasma protein ranged below the detection limit of the IRMS of 0.001 atom%. With the exception of the urinary 15 NH 3 -enrichment values, the Kolmogorov-Smirnow test showed that by the majority, the data were normally distributed. When using analysis of variance, between no treatment and the three different supplementation regimes statistically significant differences of the total urinary 15 N-excretion (0-48 h) were observed: no treatment versus FP, FP versus LC1 and WPS versus LC1, respectively, (Table 2) , whereas no significant differences could be found neither for the respective faecal 22.0, 23.9 and 29.4 g N/2 days) yielded no statistically significant differences between the four tests phases (Table 4) .
Discussion
The primary metabolic function of the microbiota is the fermentation of non-digestible food ingredients that have passed the small bowel such as resistant starch, non-digestible polysaccharides, non-digestible oligosaccharides and proteins and others. During this passage, these substrates are exposed to the differing conditions of the gastrointestinal tract and are then found nearly indigested in the faeces of the large bowel (Wutzke and Oetjens, 2005) . The outcome of the subsequent complex metabolic activity of the colon is the supply of energy and the retrieval of reusable substrates for the microbiota itself, and, consequently, for the host. The protein degradation in the large bowel leads to the generation of amino acids (which can be further partly deaminated to ammonia) and of other potentially toxic metabolic end products such as phenols, indoles, amines and others ( Smith and Macfarlane, 1996) . In vivo studies have been shown that the ammonia generation and accumulation, respectively, can be reduced by lowering the protein supply and by the colonic fermentation of suitable non-digestible carbohydrates of the food (Geboes et al., 2005) . In contrast to polysaccharides, preferably butyric acid is generated in the colon during the fermentation of resistant starch. However, the resulting generation of both short chain fatty acids and butyric acid lead to a decrease of the pH value in the colon, and, consequently, to an inhibition of the protease activity, whereas the additional energy supply increases the total bacterial mass (Macfarlane and Cummings, 1991) . In combination, these effects lead to an increased incorporation of both amino acid nitrogen and ammonia by the microbiota. The Leuven group recently showed that after 15 N-LU administration the supplementation of type-3 resistant starch (RS3) in comparison with baseline significantly reduced the renal 15 N-excretion (Cloetens et al., 2008b) .
Furthermore, the study revealed that the major part of 15 N was excreted between 6 and 24 h after 15 N-LU ingestion suggesting that the 15 NH 3 had not reached the distal colon, and, therefore, it only justifies the evaluation of the degradation processes in the proximal colon. When considering the results of this study, our data are in the same order of magnitude of those of the Leuven studies and confirm the tendency of lowering the urinary 15 N-excretion after supplementation with prebiotics when using 15 N-LU (De Preter et al., 2004; Geboes et al., 2005; Cloetens et al., 2008b) . In this study, the mean renal 15 N-excretion 48 h after 15 N-LU ingestion differed significantly between the supplementation of FP and baseline, FP and LC1, and WPS and LC1 (Table 2 ). Similar to the findings obtained after RS3 supplementation, we could confirm that the major part of 15 N was excreted in urine between 6 and 24 h after 15 N-LU ingestion, suggesting that the 15 NH 3 had not reached the distal colon (Cloetens et al., 2008b, Table 2 ). In contrast, the urinary 15 N-excretion between 0 and 6 h mainly reflects the glucose-[ 15 N 2 ]ureide absorption deriving from the enzymatic degradation of 15 N-LU by b-galactosidase in the small bowel (Wutzke and Glasenapp, 2004) . RS3 is mainly retrograded amylose formed after cooking and cooling, whereas RS2 occurs relatively dehydrated in uncooked natural granular form Figure 2 Mean urinary 15 NH 3 -enrichment over a 24-h time span after the supplementation of FPs, WPS, LC1, and no treatment when using 15 N-LU.
